5/31/2025Recent Official and Executive Moves

5/31/2025China Approves First Homegrown Nine-Valent HPV Vaccine

5/31/2025Cancer Vaccine Trials in China and the U.S. (2014–2024): A Decade of ...

5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM

5/31/2025Hengrui Medicine Gains NMPA Approval for Three New Cancer Therapies

5/31/2025Hansoh Receives NMPA Approval for Clinical Trials of Three Innovative ...

5/31/2025China Grants Conditional Approval to Zymeworks' Zanidatamab for HER2-P...

5/31/2025NMPA Issues New Regulations on Experimental Research of Narcotic and P...

5/31/2025NMPA Reopens Comment on Draft Announcement for Strengthening Oversight...

5/31/2025CSPC Eyes $5B in Licensing Deals for EGFR-ADC and Innovative Therapies

5/31/2025Astellas Enters Exclusive License Agreement with Evopoint Biosciences ...

More>>

5/22/2025China's Clinical Trial Boom (Asimov Press)

5/20/2025'China's Ozempic' may vie with Eli Lilly, Novo Nordisk for global weig...

5/20/2025How Trump's Proposed Price Cuts Could Hurt China's Innovative Drugmake...

5/16/2025US Tariffs on Pharmaceuticals Could Hit Chinese Export Firms’ Profit ...

5/16/2025SMEI: China's Pharmaceutical Industry Seeks Stability and Innovation A...

5/12/2025Trump's Drug Pricing and the US-China Trade Deal: "Our Interests are D...

5/9/2025China Still Go-To Source for New Drugs Despite Tariff Minefield (BioSp...

5/8/2025Redefining Translational Research and China's Impact on US Drug Develo...

5/5/2025China Introduces A New Regulatory Data Protection And Exclusivity Mech...

5/1/2025Pharma's Crossroads: U.S. Investment Surges Under Trump, While China F...

4/29/2025High Return Rate: Are Chinese Innovative Drugs Facing a "Breakup" Cris...

More>>